[{"PropertyPlantAndEquipmentNet_0_Q3_USD":16182000.0,"MarketableSecuritiesCurrent_0_Q3_USD":343714000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-41720000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":-14308000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":108247000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":36016000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":117663038.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":118168063.0,"DueFromRelatedPartiesCurrent_0_Q3_USD":8000000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":-41720000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":-14308000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":8691000.0,"InterestPaidNet_3_Q3_USD":13281000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":461000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-136011000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":1000.0,"ProceedsFromMinorityShareholders_3_Q3_USD":24094000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1485000.0,"AssetsCurrent_0_Q3_USD":745384000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-7324000.0,"TreasuryStockShares_0_Q3_shares":2414681.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":26180686.0,"TreasuryStockValue_0_Q3_USD":75000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2399000.0,"CommonStockSharesIssued_0_Q3_shares":124957091.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":609388000.0,"Assets_0_Q3_USD":787693000.0,"ShareBasedCompensation_3_Q3_USD":46313000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":9644000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OperatingLeaseLiability_0_Q3_USD":11853000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-397000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":207000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":4706000.0,"IncreaseDecreaseInDueFromRelatedParties_3_Q3_USD":5155000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1075000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":246873000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":92050000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":13876000.0,"MinorityInterest_0_Q3_USD":52057000.0,"ProceedsFromStockPlans_3_Q3_USD":1205000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-1344000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":9000.0,"CommonStockValue_0_Q3_USD":125000.0,"TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0_Q3_USD":2574000.0,"EmployeeBenefitsAndShareBasedCompensation_3_Q3_USD":0.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":2395000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":442658000.0,"MinorityInterestPeriodIncreaseDecrease_1_Q3_USD":-799000.0,"RestrictedCash_0_Q3_USD":424000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":139016000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-328743000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-115859000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-328536000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-116256000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":547000.0,"OtherAssetsNoncurrent_0_Q3_USD":16483000.0,"NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_1_Q3_USD":-13177000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":366967000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":8236000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1006944000.0,"Liabilities_0_Q3_USD":569306000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q3_USD":11748000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":2023000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":1224000.0,"LeaseCost_3_Q3_USD":3242000.0,"LeaseCost_1_Q3_USD":1252000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":3194000.0,"ProceedsFromConvertibleDebt_3_Q3_USD":550000000.0,"CommonStockSharesOutstanding_0_Q3_shares":122542410.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":269802000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":462000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":147000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":243000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-303453000.0,"NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_1_Q3_USD":7267000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":3895000.0,"LiabilitiesCurrent_0_Q3_USD":75707000.0,"AccountsPayableCurrent_0_Q3_USD":9839000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-768774000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":13039000.0,"NonoperatingIncomeExpense_1_Q3_USD":-10228000.0,"InterestExpense_3_Q3_USD":25693000.0,"InterestExpense_1_Q3_USD":10929000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":26703000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":2921000.0,"LongTermDebtNoncurrent_0_Q3_USD":93392000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.059,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":194000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":367391000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":215813000.0,"OperatingLeasePayments_3_Q3_USD":2700000.0,"OperatingLeasePayments_1_Q3_USD":1100000.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_3_Q3_USD":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"NonoperatingIncomeExpense_3_Q3_USD":-23470000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-130564000.0,"VariableLeaseCost_1_Q3_USD":257000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":608927000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":5391000.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":8127000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":8127000.0,"OperatingIncomeLoss_3_Q3_USD":-346993000.0,"OperatingIncomeLoss_1_Q3_USD":-119939000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":75000000.0,"InvestmentIncomeInterest_3_Q3_USD":3567000.0,"InvestmentIncomeInterest_1_Q3_USD":692000.0,"PreferredStockValue_0_Q3_USD":null,"OperatingLeaseCost_3_Q3_USD":2684000.0,"OperatingLeaseCost_1_Q3_USD":995000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":787693000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":18755000.0,"VariableLeaseCost_3_Q3_USD":558000.0,"PreferredStockSharesAuthorized_0_Q3_shares":25000000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":17699000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3617000.0,"OperatingExpenses_3_Q3_USD":355120000.0,"OperatingExpenses_1_Q3_USD":128066000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":4890000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":11814000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.79,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.98,"ProfitLoss_3_Q3_USD":-370463000.0,"ProfitLoss_1_Q3_USD":-130167000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":13469000.0,"StockholdersEquity_0_Q3_USD":163756000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":5372000.0,"AccretionExpense_3_Q3_USD":12315000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":46313000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-370256000.0,"Ticker":"BBIO","CIK":"1743881","name":"BRIDGEBIO PHARMA, INC.","OfficialName":"BridgeBio Pharma Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1594164456.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]